I've been feeling that way for five or six months. B-UP Topline and B-OM interim couldn't get us some lasting traction. With the Prurisol interim delay from Q2 to Q3 and now rumors of no interim results coming, the nearly limitless buffet of shares in the 0.70s has persisted for what seems like an eternity. I have enjoyed gorging myself on stock priced at 2009 levels, back when we had no clinical trials started, in the depths of a recession. I tire of their taste at times but I continue to fill my belly with the delectable little morsels of stock.
Hopefully locking in good B-OM top line data in the next month or two will light a fire under this thing. Anticipation of P2B results should begin to mount. And what an interesting peak at Kevetrin we will have in December. Interesting times coming for IPIX to be sure.
For those who haven't bought in yet, now might be a good time. Nothing feels better than skipping the eight-years wait and using the fast pass a month or three before showtime.
Go IPIX!
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
All my posts are my own personal opinion and speculation. They should not be used as the basis for any investment decision. No, I am not Scottsmith.